Holen Sie sich die Stockscreener-App
7.88
0.64%
0.05
Handel nachbörslich:
8.13
0.25
+3.17%
Alpha Tau Medical Ltd Aktie (DRTS) Neueste Nachrichten
DRTS Options Volatility — NASDAQ:DRTS - TradingView — Track All Markets
DRTS Options Chain — NASDAQ:DRTS - TradingView — Track All Markets
Shorts Report: Will Alpha Tau Medical Ltd Equity Warrant stock benefit from M A2026 Earnings Surprises & High Return Trade Guides - baoquankhu1.vn
Growth Recap: Will Alpha Tau Medical Ltd Equity Warrant benefit from rising consumer demandQuarterly Trade Review & High Conviction Investment Ideas - baoquankhu1.vn
Jobs Data: Can Alpha Tau Medical Ltd continue delivering strong returnsEarnings Overview Summary & Safe Capital Preservation Plans - baoquankhu1.vn
FOMO Trade: Will Alpha Tau Medical Ltd Equity Warrant stock benefit from M A2026 Geopolitical Influence & AI Based Trade Execution Alerts - baoquankhu1.vn
Daytona Street Capital LLC Invests $749,000 in Alpha Tau Medical Ltd. $DRTS - MarketBeat
DRTS PE Ratio & Valuation, Is DRTS Overvalued - Intellectia AI
DRTS SEC FilingsAlpha Tau Medical Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Alpha Emitter Market Set to Boom Rapidly, Witnessing Strong - openPR.com
Piper Sandler cuts Alpha Tau Medical stock rating on valuation - Investing.com
Stop Loss: How does Alpha Tau Medical Ltd compare to its peersTrade Signal Summary & Weekly Breakout Stock Alerts - baoquankhu1.vn
Alpha Tau is Firing on All Cylinders: Japan Approval, 5 US Trials, And Now Pancreatic Data Heads to DDW - TipRanks
Alpha Tau Medical (DRTS) price target increased by 15.15% to 9.69 - MSN
Aug Update: What is Alpha Tau Medical Ltd Equity Warrants market position2026 EndofYear Setup & Growth Focused Investment Plans - baoquankhu1.vn
Alpha Tau Wins First DDW Oral Slot for Alpha DaRT Pancreatic Cancer Data - TipRanks
Aug EndMonth: Why is Alpha Tau Medical Ltd stock going down2026 Sentiment & Daily Profit Maximizing Tips - baoquankhu1.vn
Alpha Tau Medical to Present First Oral Data on Alpha DaRT Technology for Pancreatic Cancer at DDW 2026 - geneonline.com
Alpha Tau Medical (Nasdaq: DRTS) wins DDW 2026 oral slot for Alpha DaRT pancreatic cancer trials - Stock Titan
Alpha Tau Announces First-Ever Oral Presentation of Alpha - GlobeNewswire
Resistance Check: Is Alpha Tau Medical Ltd forming a bullish divergenceDollar Strength & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Aug Spikes: Should I invest in Alpha Tau Medical Ltd before earningsWeekly Trading Summary & Weekly Market Pulse Alerts - baoquankhu1.vn
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Aug Ideas: Will Alpha Tau Medical Ltd Equity Warrant stock benefit from M AQuarterly Earnings Summary & Weekly Hot Stock Watchlists - baoquankhu1.vn
Oramed (NASDAQ: ORMP) pivots with Lifeward deal and Alpha Tau stake - Stock Titan
US Stocks Recap: What is Alpha Tau Medical Ltd Equity Warrants market positionMarket Movers & Community Verified Trade Signals - baoquankhu1.vn
Alpha Tau Medical Ltd. (DRTS) Competitors - Meyka
Alpha Tau Medical: 2026 Is The Breakthrough Year - Seeking Alpha
What is the Moat Score of Alpha Tau Medical Ltd2026 Closing Moves & Consistent Return Investment Signals - baoquankhu1.vn
Aug Action: Is Alpha Tau Medical Ltd Equity Warrant benefiting from interest rate changes2026 Winners & Losers & Safe Capital Growth Tips - baoquankhu1.vn
Is Alpha Tau Medical Ltd forming a bullish divergence2026 Year in Review & Real-Time Buy Signal Notifications - baoquankhu1.vn
Alpha Tau Medical (NASDAQ:DRTS) Shares Gap UpHere's Why - MarketBeat
Alpha Tau Medical Conference: Japan Approval, Rolling FDA PMA, and Big 2026 Data Readouts Teased - MarketBeat
Resistance Check: Is Alpha Tau Medical Ltd Equity Warrant benefiting from interest rate changesRate Hike & Daily Volume Surge Signals - baoquankhu1.vn
Alpha Tau Medical (DRTS) director details shares, options and RSUs - Stock Titan
Alpha Tau (DRTS) director discloses initial shares, RSUs and options - Stock Titan
Alpha Tau Medical (NASDAQ: DRTS) CEO details equity holdings - Stock Titan
Alpha Tau Medical (DRTS) director Alan Adler details share and option holdings - Stock Titan
Alpha Tau Medical (DRTS) director discloses shares, RSUs and options - Stock Titan
Alpha Tau Medical (DRTS) director details shares, options and warrants - Stock Titan
Alpha Tau Medical (NASDAQ: DRTS) director discloses initial shares, RSUs and option grants - Stock Titan
Alpha Tau Medical (NASDAQ: DRTS) director details initial equity holdings - Stock Titan
Alpha Tau Medical (DRTS) CFO Raphi Levy reports detailed insider holdings - Stock Titan
Pullback Watch: Can Alpha Tau Medical Ltd Equity Warrant reach all time highs this year2026 Top Gainers & Safe Swing Trade Setups - baoquankhu1.vn
Aug EndMonth: Will Alpha Tau Medical Ltd Equity Warrant benefit from rising consumer demandPortfolio Gains Report & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Is Alpha Tau Medical Ltd stock showing strong momentum2026 Spike Watch & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Market Recap: Is Alpha Tau Medical Ltd Equity Warrant stock overvalued or fairly priced2026 Trading Volume Trends & Weekly Stock Breakout Alerts - baoquankhu1.vn
Alpha Tau to Present at Sidoti March Virtual Small Cap Conference - GlobeNewswire
Citigroup maintains Alpha Tau Medical (DRTS) buy recommendation - MSN
Piper Sandler cuts Alpha Tau Medical stock rating on valuation By Investing.com - Investing.com Nigeria
Alpha Tau Medical’s innovative prostate cancer therapy: study completion update - MSN
Fund Flows: What is the PEG ratio of Alpha Tau Medical Ltd2026 Institutional Moves & Low Risk Entry Point Tips - baoquankhu1.vn
Citigroup Forecasts Strong Price Appreciation for Alpha Tau Medical (NASDAQ:DRTS) Stock - Defense World
HC Wainwright Has Negative Estimate for DRTS Q1 Earnings - Defense World
Short Squeeze: Will Alpha Tau Medical Ltd benefit from rate cuts2026 Fundamental Recap & Low Drawdown Momentum Ideas - baoquankhu1.vn
HC Wainwright Issues Pessimistic Estimate for DRTS Earnings - MarketBeat
Citigroup Increases Alpha Tau Medical (NASDAQ:DRTS) Price Target to $9.00 - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) Given Buy Rating at HC Wainwright - Defense World
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):